Fresh data supports updated boosters targeting omicron subvariants, raising hopes more Americans will get the shot
A flurry of announcements Thursday on COVID vaccines and boosters offered further evidence and support…
Read MoreA flurry of announcements Thursday on COVID vaccines and boosters offered further evidence and support…
Read MoreA flurry of announcements Thursday on COVID vaccines and boosters offered further evidence and support…
Read MoreGSK PLC said Thursday that a Phase 3 trial of its respiratory syncytial virus vaccine…
Read MoreWhen MarketWatch first started delivering financial news and data exclusively online in 1997, about half…
Read MoreWe are marking MarketWatch’s 25th anniversary by looking at the 25 biggest financial market events…
Read MoreCloud-based communication company RingCentral has been added to the list of “zombie” stocks compiled by…
Read MoreWant to understand the impact of Fed Chairman Ben Bernanke’s research that won him and…
Read MoreAs cryptocurrency enthusiasts look to build out the future of money, some are looking back…
Read MoreA pair of new drugs offer something many Americans desperately want: a way to lose…
Read MoreMost financial planners advise young people to start saving early — and often — for…
Read More